Follow
Charbel Sandroussi
Charbel Sandroussi
Clinical Associate Professor, University of Sydney
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion
D DuBay, C Sandroussi, L Sandhu, S Cleary, M Guba, MS Cattral, ...
Annals of surgery 253 (1), 166-172, 2011
3142011
Benefit of treating hepatocellular carcinoma recurrence after liver transplantation and analysis of prognostic factors for survival in a large Euro-American series
G Sapisochin, N Goldaracena, S Astete, JM Laurence, D Davidson, ...
Annals of surgical oncology 22, 2286-2294, 2015
1702015
Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma?
G Spolverato, A Vitale, A Cucchetti, I Popescu, HP Marques, L Aldrighetti, ...
Cancer 121 (22), 3998-4006, 2015
1642015
A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer
JM Laurence, PD Tran, K Morarji, GD Eslick, VWT Lam, C Sandroussi
Journal of Gastrointestinal Surgery 15 (11), 2059-2069, 2011
1622011
Systematic review and meta‐analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma
S Abbas, C Sandroussi
HPB 15 (7), 492-503, 2013
1522013
Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma
C Sandroussi, LA Dawson, M Lee, M Guindi, S Fischer, A Ghanekar, ...
Transplant international 23 (3), 299-306, 2010
1102010
Targeting DNA damage response and replication stress in pancreatic cancer
SB Dreyer, R Upstill-Goddard, V Paulus-Hock, C Paris, EM Lampraki, ...
Gastroenterology 160 (1), 362-377. e13, 2021
1072021
Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor
DJ Arnaoutakis, Y Kim, C Pulitano, V Zaydfudim, MH Squires, D Kooby, ...
Annals of surgery 261 (2), 361-367, 2015
1072015
Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients
G Spolverato, Y Kim, A Ejaz, S Alexandrescu, H Marques, L Aldrighetti, ...
JAMA surgery 150 (6), 538-545, 2015
1032015
HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer
H Brunton, G Caligiuri, R Cunningham, R Upstill-Goddard, UM Bailey, ...
Cell reports 31 (6), 2020
942020
Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration
G Spolverato, Y Kim, S Alexandrescu, I Popescu, HP Marques, ...
Annals of surgical oncology 22, 2218-2225, 2015
942015
Coping with newly diagnosed upper gastrointestinal cancer: a longitudinal qualitative study of family caregivers’ role perception and supportive care needs
J Shaw, J Harrison, J Young, P Butow, C Sandroussi, D Martin, ...
Supportive care in cancer 21, 749-756, 2013
882013
Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation
DA DuBay, C Sandroussi, JR Kachura, CS Ho, JR Beecroft, CM Vollmer, ...
Hpb 13 (1), 24-32, 2011
832011
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence
L Sandhu, C Sandroussi, M Guba, M Selzner, A Ghanekar, MS Cattral, ...
Liver Transplantation 18 (3), 315-322, 2012
822012
Preoperative assessment of postoperative liver function: the importance of residual liver volume
C Pulitano, M Crawford, D Joseph, L Aldrighetti, C Sandroussi
Journal of Surgical Oncology 110 (4), 445-450, 2014
702014
A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms
N Abraham, L Lemech, C Sandroussi, D Sullivan, J May
Journal of vascular surgery 41 (3), 377-380, 2005
672005
Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs
J Kokkinos, RMC Ignacio, G Sharbeen, C Boyer, E Gonzales-Aloy, ...
Biomaterials 240, 119742, 2020
582020
Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries
SW Ryu, R Saw, RA Scolyer, M Crawford, JF Thompson, C Sandroussi
Journal of surgical oncology 108 (2), 129-135, 2013
562013
Living donor hepatectomy: the importance of the residual liver volume
TW Reichman, C Sandroussi, SM Azouz, L Adcock, MS Cattral, ...
Liver Transplantation 17 (12), 1404-1411, 2011
532011
A multi‐institution analysis of outcomes of liver‐directed surgery for metastatic renal cell cancer
I Hatzaras, AL Gleisner, C Pulitano, C Sandroussi, K Hirose, O Hyder, ...
HPB 14 (8), 532-538, 2012
522012
The system can't perform the operation now. Try again later.
Articles 1–20